mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant
UMB Dataset
UID: 189
Author(s):
Etsuro Nanishi,
Marisa E. McGrath,
Timothy R. O’Meara,
Soumik Barman,
Jingyou Yu,
Huahua Wan,
Carly A. Dillen,
Manisha Menon,
Hyuk-Soo Seo,
Kijun Song,
Andrew Z. Xu,
Luke Sebastian,
Byron Brook,
Anna-Nicole Bosco,
Francesco Borriello,
Robert K. Ernst,
Dan H. Barouch,
Sirano Dhe-Paganon,
Ofer Levy,
Matthew B. Frieman,
David J. Dowling** Corresponding Author
Description
This study investigates multiple vaccine strategies to enhance immunogenicity and protection against SARS-CoV-2 in aged mice. The study aims to determine the effect of a booster dose, with an emphasis on older age. Female three and eleven-month-old BALB/c mice were studied over the course of 38 weeks. Mice received BNT162b2 SARS-CoV-2 spike mRNA vaccine series, primary vaccination series, and mock Phosphate-buffered saline (PBS) injections. Single mouse experiments aimed to include 20 mice per group. Sample size and age criteria were chosen empirically based on the results of previous studies. Mice were randomly assigned to different treatment groups.
All data supporting the findings of this study are available within
the supplementary information files (Supplementary Data 1). The data corresponds to the figures that are in the article.
Benchtop high-performance cell sorter with multiple lazer, detector and fluoroscrome options. Allows detection of 12 parameters (10 color conjugates, forward and sideward scatter).